Jones Financial Companies’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
4,303
+3,014
+234% +$13K ﹤0.01% 3572
2026
Q1
$4.92K Buy
1,289
+1,155
+862% +$4.85K ﹤0.01% 3849
2025
Q4
$462 Hold
134
﹤0.01% 4177
2025
Q3
$697 Hold
134
﹤0.01% 3972
2025
Q2
$730 Hold
134
﹤0.01% 3726
2025
Q1
$1.17K Hold
134
﹤0.01% 3366
2024
Q4
$1.72K Hold
134
﹤0.01% 3039
2024
Q3
$1.44K Buy
+134
New +$1.26K ﹤0.01% 2746

Other funds holding RCEL

Jones Financial Companies's RCEL Position: Q2 2026 in Review

Jones Financial Companies increased its Avita Medical (RCEL) stake by 234% in Q2 2026, buying an estimated $13K and bringing the position to 4,303 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3572.

Jones Financial Companies first reported a position in RCEL in Q3 2024 and has held it in 8 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Jones Financial Companies held 4,303 shares of Avita Medical worth $17.1K as of Q2 2026.
  • Jones Financial Companies bought 3,014 Avita Medical shares in Q2 2026, an estimated $13K.
  • Avita Medical made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3572 holding.
  • Jones Financial Companies first reported a position in Avita Medical in Q3 2024 and has held it in 8 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.